
Scorpius Holdings Inc (SCPX) - Financial and Strategic SWOT Analysis Review
Description
Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Laerdal Medical AS (Laerdal Medical) provides training and therapies of resuscitation education products for lifesaving emergency medicine. The company provides range of training, educational and therapy products for emergency medical care and lifesaving. It offers medical devices such as ventilation, CPR barrier devices, suction units for airway management. Laerdal Medical also offers various immobilization products, including extrication collars, tube holders, head immobilizers, alignment pads, spine boards and others. It provides educational and technical services. The company markets products through subsidiaries and through a network of government and private distributors in the Americas, Europe and Asia Pacific. Laerdal Medical is headquartered in Stavanger, Norway.
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Laerdal Medical AS (Laerdal Medical) provides training and therapies of resuscitation education products for lifesaving emergency medicine. The company provides range of training, educational and therapy products for emergency medical care and lifesaving. It offers medical devices such as ventilation, CPR barrier devices, suction units for airway management. Laerdal Medical also offers various immobilization products, including extrication collars, tube holders, head immobilizers, alignment pads, spine boards and others. It provides educational and technical services. The company markets products through subsidiaries and through a network of government and private distributors in the Americas, Europe and Asia Pacific. Laerdal Medical is headquartered in Stavanger, Norway.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
47 Pages
- Section 1 - About the Company
- Scorpius Holdings Inc - Key Facts
- Scorpius Holdings Inc - Key Employees
- Scorpius Holdings Inc - Key Employee Biographies
- Scorpius Holdings Inc - Major Products and Services
- Scorpius Holdings Inc - History
- Scorpius Holdings Inc - Company Statement
- Scorpius Holdings Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Scorpius Holdings Inc - Business Description
- Scorpius Holdings Inc - Corporate Strategy
- Scorpius Holdings Inc - SWOT Analysis
- SWOT Analysis - Overview
- Scorpius Holdings Inc - Strengths
- Scorpius Holdings Inc - Weaknesses
- Scorpius Holdings Inc - Opportunities
- Scorpius Holdings Inc - Threats
- Scorpius Holdings Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Scorpius Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Scorpius Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Scorpius Holdings Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Sep 09, 2024: Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA
- Aug 26, 2024: Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, And Path Toward Positive Cash Flow
- Aug 06, 2024: Scorpius Holdings Weighted-average Pipeline Surpasses $100 Million In Business Develop Opportunities Across Both Manufacturing Client And Government Sectors
- Jul 24, 2024: Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter
- Jul 18, 2024: Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility
- Jun 30, 2024: Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024
- Jun 03, 2024: Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing
- May 29, 2024: Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
- May 20, 2024: Scorpius Holdings Announces Major Expansion In San Antonio With New State-of-the-art Storage And Testing Facility
- May 16, 2024: Scorpius Holdings Commends Congress on Bipartisan Legislative Action Aimed at Bolstering U.S. Biomanufacturing
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Scorpius Holdings Inc, Key Facts
- Scorpius Holdings Inc, Key Employees
- Scorpius Holdings Inc, Key Employee Biographies
- Scorpius Holdings Inc, Major Products and Services
- Scorpius Holdings Inc, History
- Scorpius Holdings Inc, Subsidiaries
- Scorpius Holdings Inc, Key Competitors
- Scorpius Holdings Inc, Ratios based on current share price
- Scorpius Holdings Inc, Annual Ratios
- Scorpius Holdings Inc, Annual Ratios (Cont...1)
- Scorpius Holdings Inc, Annual Ratios (Cont...2)
- Scorpius Holdings Inc, Interim Ratios
- Scorpius Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Scorpius Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
- Scorpius Holdings Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Scorpius Holdings Inc, Performance Chart (2019 - 2023)
- Scorpius Holdings Inc, Ratio Charts
- Scorpius Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
- Scorpius Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.